212 results on '"Dippel, Diederik"'
Search Results
2. Sex Differences in Prehospital Identification of Large Vessel Occlusion in Patients With Suspected Stroke
- Author
-
Ali, Mariam, Dekker, Luuk, Daems, Jasper D., Ali, Mahsoem, van Zwet, Erik W., Steyerberg, Ewout W., Duvekot, Martijne H.C., Nguyen, T. Truc My, Moudrous, Walid, van de Wijdeven, Ruben M., Visser, Marieke C., de Laat, Karlijn F., Kerkhoff, Henk, van den Wijngaard, Ido R., Dippel, Diederik W.J., Roozenbeek, Bob, Kruyt, Nyika D., Wermer, Marieke J.H., Aerden, Leo A.M., Alblas, Kees C.L., Bakker, Jeannette, van Belle, Eduard, Bevelander, Timo, Bosch, Jan, Buijck, Bianca, Dofferhoff-Vermeulen, Tamara, van Doormaal, Pieter Jan, Dorresteijn, Kirsten R.I.S., Duijndam, Dion, van Eijkelenburg, Roeland P.J., van Es, Adriaan C.G.M., Hensen, Jan-Hein, Hoek, Amber, Kloos, Loet M.H., Koster, Gaia T., Kuiper, Jan Willem, de Leeuw, Arnoud M., Lingsma, Hester F., van der Lugt, Aad, Lycklama À Nijeholt, Geert, Maasland, Lisette, van Moll, Bruno J.M., Mulder, Laus J.M.M., Noordam-Reijm, Anja, Oskam, Erick, Plaisier, Aarnout, Rozeman, Anouk D., de Schryver, Els L.L.M., Venema, Esmee, Wijnhoud, Annemarie D., Willeboer, Merel L., Woudenberg, Mirjam, van der Zon, Mandy M.A., Zwets, Egon D., and Zylicz, Stas A.
- Published
- 2024
- Full Text
- View/download PDF
3. Endovascular therapy in acute ischemic stroke with poor reperfusion is associated with worse outcomes compared with best medical management: a HERMES substudy
- Author
-
Rex, Nathaniel, Ospel, Johanna M, Brown, Scott B, McDonough, Rosalie V, Kashani, Nima, Hill, Michael D, Dippel, Diederik W J, Campbell, Bruce, Muir, Keith W, Demchuk, Andrew M, Bracard, Serge, Guillemin, Francis, Jovin, Tudor G, Mitchell, Peter J, White, Phil, Majoie, Charles B L M, Saver, Jeffrey L, and Goyal, Mayank
- Abstract
BackgroundFunctional outcomes in patients with acute ischemic stroke (AIS) with large vessel occlusion (LVO) undergoing endovascular treatment (EVT) with poor reperfusion were compared with patients with AIS-LVO treated with best medical management only.MethodsData are from the HERMES collaboration, a patient-level meta-analysis of seven randomized EVT trials. Baseline characteristics and functional outcomes (modified Rankin Scale (mRS) score at 90 days) were compared between patients with poor reperfusion (defined as modified Thrombolysis in Cerebral Infarction Score 0–1 on the final intracranial angiography run as assessed by the central imaging core laboratory) and patients in the control arm with multivariable logistic ordinal logistic regression adjusted for pre-specified baseline variables.Results972 of 1764 patients from the HERMES collaboration were included in the analysis: 893 in the control arm and 79 in the EVT arm with final mTICI 0–1. Patients with poor reperfusion who underwent EVT had higher baseline National Institutes of Health Stroke Scale than controls (median 19 (IQR 15.5–21) vs 17 (13–21), P=0.011). They also had worse mRS at 90 days compared with those in the control arm in adjusted analysis (median 4 (IQR 3–6) vs median 4 (IQR 2–5), adjusted common OR 0.59 (95% CI 0.38 to 0.91)). Symptomatic intracranial hemorrhage was not different between the two groups (3.9% vs 3.5%, P=0.75, adjusted OR 0.94 (95% CI 0.23 to 3.88)).ConclusionPoor reperfusion after EVT was associated with worse outcomes than best medical management, although no difference in symptomatic intracranial hemorrhage was seen. These results emphasize the need for additional efforts to further improve technical EVT success rates.
- Published
- 2024
- Full Text
- View/download PDF
4. Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation
- Author
-
van Voorst, Henk, Hoving, Jan W, Koopman, Miou S, Daems, Jasper D, Peerlings, Daan, Buskens, Erik, Lingsma, Hester, Marquering, Henk A, de Jong, Hugo W A M, Berkhemer, Olvert A, van Zwam, Wim H, van Walderveen, Marianne A A, van den Wijngaard, Ido R, Dippel, Diederik W J, Yoo, Albert J, Campbell, Bruce, Kunz, Wolfgang G, Majoie, Charles B, and Emmer, Bart J
- Abstract
BackgroundAlthough CT perfusion (CTP) is often incorporated in acute stroke workflows, it remains largely unclear what the associated costs and health implications are in the long run of CTP-based patient selection for endovascular treatment (EVT) in patients presenting within 6 hours after symptom onset with a large vessel occlusion.MethodsPatients with a large vessel occlusion were included from a Dutch nationwide cohort (n=703) if CTP imaging was performed before EVT within 6 hours after stroke onset. Simulated cost and health effects during 5 and 10 years follow-up were compared between CTP based patient selection for EVT and providing EVT to all patients. Outcome measures were the net monetary benefit at a willingness-to-pay of €80 000 per quality-adjusted life year, incremental cost-effectiveness ratio), difference in costs from a healthcare payer perspective (ΔCosts) and quality-adjusted life years (ΔQALY) per 1000 patients for 1000 model iterations as outcomes.ResultsCompared with treating all patients, CTP-based selection for EVT at the optimised ischaemic core volume (ICV≥110 mL) or core-penumbra mismatch ratio (MMR≤1.4) thresholds resulted in losses of health (median ΔQALYs for ICV≥110 mL: −3.3 (IQR: −5.9 to −1.1), for MMR≤1.4: 0.0 (IQR: −1.3 to 0.0)) with median ΔCosts for ICV≥110 mL of −€348 966 (IQR: −€712 406 to −€51 158) and for MMR≤1.4 of €266 513 (IQR: €229 403 to €380 110)) per 1000 patients. Sensitivity analyses did not yield any scenarios for CTP-based selection of patients for EVT that were cost-effective for improving health, including patients aged ≥80 yearsConclusionIn EVT-eligible patients presenting within 6 hours after symptom onset, excluding patients based on CTP parameters was not cost-effective and could potentially harm patients.
- Published
- 2024
- Full Text
- View/download PDF
5. Endovascular treatment of patients with stroke caused by anterior cerebral artery occlusions
- Author
-
Vos, Erik M., Kappelhof, Manon, den Hartog, Sanne J., Coutinho, Jonathan M., Emmer, Bart J., Roozenbeek, Bob, van Zwam, Wim H., van Oostenbrugge, Robert J., van der Worp, H. Bart, Uyttenboogaart, Maarten, van Es, Adriaan C. G. M., Majoie, Charles B. L. M., Dippel, Diederik W. J., Peeters-Scholte, Cacha M. P. C. D., and van den Wijngaard, Ido R.
- Abstract
Background: Occlusion of the anterior cerebral artery (ACA) is uncommon but may lead to significant disability. The benefit of endovascular treatment (EVT) for ACA occlusions remains uncertain. Methods: We included patients treated with EVT and compared patients with ACA occlusions with patients who had internal carotid artery (ICA) or proximal (M1/M2) middle cerebral artery (MCA) occlusions from the MR CLEAN Registry. Primary outcome was the modified Rankin Scale score (mRS). Secondary outcomes were functional independence (mRS 0–2), National Institutes of Health Stroke Scale (NIHSS) score, delta-NIHSS (baseline minus NIHSS score at 24–48 h), and successful recanalization (expanded thrombolysis in cerebral infarction (eTICI) score 2b-3). Safety outcomes were symptomatic intracranial hemorrhage (sICH), periprocedural complications, and mortality. Results: Of 5193 patients, 11 (0.2%) had primary ACA occlusions. Median NIHSS at baseline was lower in patients with ACA versus ICA/MCA occlusions (11, IQR 9–14; versus 15, IQR 11–19). Functional outcome did not differ from patients with ICA/MCA occlusions. Functional independence was 4/11 (36%) in patients with ACA versus 1949/4815 (41%) in ICA/MCA occlusions; median delta-NIHSS was − 1 (IQR − 7 to 2) and − 4 (IQR − 9 to 0), respectively. Successful recanalization was 4/9 (44%), versus 3083/4787 (64%) in ICA/MCA occlusions. Mortality was 3/11 (27%) versus 1263/4815 (26%). One patient with ACA occlusion had sICH; no other complications occurred. Conclusion: In this cohort ACA occlusions were uncommon. Functional outcome did not differ between patients with ACA occlusions and ICA/MCA occlusions. Prospective research is needed to determine feasibility, safety, and outcomes of EVT for ACA occlusions.
- Published
- 2024
- Full Text
- View/download PDF
6. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice
- Author
-
van Voorst, Henk, Bruggeman, Agnetha A.E., Andriessen, Jurr, Hoving, Jan W., Konduri, Praneeta R., Yang, Wenjin, Kappelhof, Manon, Arrarte Terreros, Nerea, Roos, Yvo B.W.E.M., van Zwam, Wim H., van der Lugt, Aad, van der Hoorn, Anouk, Boiten, Jelis, Roosendaal, Stefan, Jenniskens, Sjoerd, Caan, Matthan W.A., Marquering, Henk A., Emmer, Bart J., Majoie, Charles B.L.M., Dippel, Diederik W.J., van Oostenbrugge, Robert J., Vos, Jan Albert, Jansen, Ivo G.H., Mulder, Maxim J.H.L., Goldhoorn, Robert- Jan B., Compagne, Kars C.J., Brouwer, Josje, den Hartog, Sanne J., Hinsenveld, Wouter H., Dippel, Diederik W.J., Roozenbeek, Bob, van Es, Adriaan C.G.M., Coutinho, Jonathan M., Schonewille, Wouter J., Vos, Jan Albert, Wermer, Marieke J.H., van Walderveen, Marianne A.A., Staals, Julie, van Oostenbrugge, Robert J., Hofmeijer, Jeannette, Martens, Jasper M., Lycklama à Nijeholt, Geert J., de Bruijn, Sebastiaan F., van Dijk, Lukas C., van der Worp, H. Bart, Lo, Rob H., van Dijk, Ewoud J., Boogaarts, Hieronymus D., de Vries, J., de Kort, Paul L.M., van Tuijl, Julia, Peluso, Jo P., Fransen, Puck, van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Uyttenboogaart, Maarten, Eschgi, Omid, Bokkers, Reinoud P.H., Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Yo, Lonneke S.F., den Hertog, Heleen M., Sturm, Emiel J.C., Brouwers, Paul J.A.M., Lycklama à Nijeholt, Geert J., van Walderveen, Marianne A.A., Sprengers, Marieke E.S., van den Berg, René, Yoo, Albert J., Beenen, Ludo F.M., Postma, Alida A., van der Kallen, Bas F.W., van den Wijngaard, Ido R., van Es, Adriaan C.G.M., Martens, Jasper M., Yo, Lonneke S.F., Vos, Jan Albert, Bot, Joost, van Doormaal, Pieter-Jan, Meijer, Anton, Ghariq, Elyas, Bokkers, Reinoud P.H., van Proosdij, Marc P., Krietemeijer, G. Menno, Peluso, Jo P., Boogaarts, Hieronymus D., Lo, Rob, Gerrits, Dick, Dinkelaar, Wouter, Appelman, Auke P.A., Hammer, Bas, Pegge, Sjoert, Vinke, Saman, Dippel, Diederik W.J., van Oostenbrugge, Robert J., Lycklama à Nijeholt, Geert J., Vos, Jan Albert, Schonewille, Wouter J., Hofmeijer, Jeannette, Martens, Jasper M., van der Worp, H. Bart, Lo, Rob H., van Oostenbrugge, Robert J., Hofmeijer, Jeannette, Flach, H. Zwenneke, Lingsma, Hester F., el Ghannouti, Naziha, Sterrenberg, Martin, Pellikaan, Wilma, Sprengers, Rita, Elfrink, Marjan, Simons, Michelle, Vossers, Marjolein, de Meris, Joke, Vermeulen, Tamara, Geerlings, Annet, van Vemde, Gina, Simons, Tiny, Messchendorp, Gert, Nicolaij, Nynke, Bongenaar, Hester, Bodde, Karin, Kleijn, Sandra, Lodico, Jasmijn, Droste, Hanneke, Wollaert, Maureen, Verheesen, Sabrina, Jeurrissen, D., Bos, Erna, Drabbe, Yvonne, Sandiman, Michelle, Aaldering, Nicoline, Zweedijk, Berber, Vervoort, Jocova, Ponjee, Eva, Romviel, Sharon, Kanselaar, Karin, Barning, Denn, Venema, Esmee, Chalos, Vicky, Geuskens, Ralph R., van Straaten, Tim, Ergezen, Saliha, Harmsma, Roger R.M., Muijres, Daan, de Jong, Anouk, Berkhemer, Olvert A., Boers, Anna M.M., Huguet, J., Groot, P.F.C., Mens, Marieke A., van Kranendonk, Katinka R., Treurniet, Kilian M., Tolhuisen, Manon L., Alves, Heitor, Weterings, Annick J., Kirkels, Eleonora L.F., Voogd, Eva J.H.F., Schupp, Lieve M., Collette, Sabine, Groot, Adrien E.D., LeCouffe, Natalie E., Prasetya, Haryadi, and Ramos, Lucas A.
- Published
- 2023
- Full Text
- View/download PDF
7. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials
- Author
-
Majoie, Charles B, Cavalcante, Fabiano, Gralla, Jan, Yang, Pengfei, Kaesmacher, Johannes, Treurniet, Kilian M, Kappelhof, Manon, Yan, Bernard, Suzuki, Kentaro, Zhang, Yongwei, Li, Fengli, Morimoto, Masafumi, Zhang, Lei, Miao, Zhongrong, Rinkel, Leon A, Huang, Jiacheng, Otsuka, Toshiaki, Wang, Shouchun, Davis, Stephen, Cognard, Christophe, Hong, Bo, Coutinho, Jonathan M, Song, Jiaxing, Chen, Wenhuo, Emmer, Bart J, Eker, Omer, Zhang, Liyong, Dobrocky, Tomas, Nguyen, Huy-Thang, Bush, Steven, Peng, Ya, LeCouffe, Natalie E, Takeuchi, Masataka, Han, Hongxing, Matsumaru, Yuji, Strbian, Daniel, Lingsma, Hester F, Nieboer, Daan, Yang, Qingwu, Meinel, Thomas, Mitchell, Peter, Kimura, Kazumi, Zi, Wenjie, Nogueira, Raul G, Liu, Jianmin, Roos, Yvo B, Fischer, Urs, Zi, Wenjie, Nogueira, Raul, Yang, Qingwu, Liu, Jianmin, Yang, Pengfei, Zhang, Yongwei, Yan, Bernard, Mitchell, Peter, Miao, Zhong Rong, Majoie, Charles B., Roos, Yvo B., Suzuki, Kentaro, Kimura, Kazumi, Matsumaru, Yuji, Fischer, Urs, Gralla, Jan, Cavalcante, Fabiano W., Kappelhof, Manon, Treurniet, Kilian M., Kaesmacher, Johannes, Zhang, Lei, Bush, Steven, Nieboer, Daan, Lingsma, Hester F., Rothwell, Peter, Saver, Jeffrey, Fiehler, Jens, Li, Fengli, Huang, Jiacheng, Song, Jiaxing, Hong, Bo, Chen, Wenhuo, Peng, Ya, Han, Hongxing, Zhang, Liyong, Li, Zifu, Xing, Pengfei, Shen, Hongjian, Zhang, Ping, Zhang, Xiaoxi, Davis, Stephen, Nguyen, Huy-Thang, Donnan, Geoffrey, Huo, Xiaochuan, Nan, Guangxian, Bivard, Andrew, Ma, Henry, Vu, Dang Lu, Campbell, Bruce, Rinkel, Leon A., Emmer, Bart J., Coutinho, Jonathan M., LeCouffe, Natalie E., Dippel, Diederik W., van der Lugt, Aad, van Zwam, Wim H., van Oostenbrugge, Robert J., Uyttenboogaart, Maarten, Costalat, Vincent, Lycklama, Geert, Hofmeijer, Jeannette, van Norden, Anouk, Otsuka, Toshiaki, Takeuchi, Masataka, Morimoto, Masafumi, Kanazawa, Ryuzaburo, Takayama, Yohei, Kamiya, Yuki, Shigeta, Keigo, Okubo, Seiji, Hayakawa, Mikito, Strbian, Daniel, Eker, Omer, Cognard, Christophe, Meinel, Thomas, Dobrocky, Tomas, Jung, Simon, Piechowiak, Eike, Marnat, Gaultier, Sibon, Igor, Bourcier, Romain, de Gaalon, Solene, Papagiannaki, Chrysanthi, and Lefebvre, Margaux
- Abstract
Intravenous thrombolysis is recommended before endovascular treatment, but its value has been questioned in patients who are admitted directly to centres capable of endovascular treatment. Existing randomised controlled trials have indicated non-inferiority of endovascular treatment alone or have been statistically inconclusive. We formed the Improving Reperfusion Strategies in Acute Ischaemic Stroke collaboration to assess non-inferiority of endovascular treatment alone versus intravenous thrombolysis plus endovascular treatment.
- Published
- 2023
- Full Text
- View/download PDF
8. Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke
- Author
-
Chalos, Vicky, Venema, Esmee, Mulder, Maxim J. H. L., Roozenbeek, Bob, Steyerberg, Ewout W., Wermer, Marieke J. H., Lycklama à Nijeholt, Geert J., van der Worp, H. Bart, Goyal, Mayank, Campbell, Bruce C. V., Muir, Keith W., Guillemin, Francis, Bracard, Serge, White, Philip, Dávalos, Antoni, Jovin, Tudor G., Hill, Michael D., Mitchell, Peter J., Demchuk, Andrew M., Saver, Jeffrey L., van der Lugt, Aad, Brown, Scott, Dippel, Diederik W. J., and Lingsma, Hester F.
- Abstract
IMPORTANCE: Outcome prediction after endovascular treatment (EVT) for ischemic stroke is important to patients, family members, and physicians. OBJECTIVE: To develop and validate a model based on preprocedural and postprocedural characteristics to predict functional outcome for individual patients after EVT. DESIGN, SETTING, AND PARTICIPANTS: A prediction model was developed using individual patient data from 7 randomized clinical trials, performed between December 2010 and December 2014. The model was developed within the Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials (HERMES) collaboration and external validation in data from the Dutch Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN) Registry of patients treated in clinical practice between March 2014 and November 2017. Participants included patients from multiple centers throughout different countries in Europe, North America, East Asia, and Oceania (derivation cohort), and multiple centers in the Netherlands (validation cohort). Included were adult patients with a history of ischemic stroke from an intracranial large vessel occlusion in the anterior circulation who underwent EVT within 12 hours of symptom onset or last seen well. Data were last analyzed in July 2022. MAIN OUTCOME(S) AND MEASURE(S): A total of 19 variables were assessed by multivariable ordinal regression to predict functional outcome (modified Rankin Scale [mRS] score) 90 days after EVT. Variables were routinely available 1 day after EVT. Akaike information criterion (AIC) was used to optimize model fit vs model complexity. Probabilities for functional independence (mRS 0-2) and survival (mRS 0-5) were derived from the ordinal model. Model performance was expressed with discrimination (C statistic) and calibration. RESULTS: A total of 781 patients (median [IQR] age, 67 [57-76] years; 414 men [53%]) constituted the derivation cohort, and 3260 patients (median [IQR] age, 72 [61-80] years; 1684 men [52%]) composed the validation cohort. Nine variables were included in the model: age, baseline National Institutes of Health Stroke Scale (NIHSS) score, prestroke mRS score, history of diabetes, occlusion location, collateral score, reperfusion grade, NIHSS score at 24 hours, and symptomatic intracranial hemorrhage 24 hours after EVT. External validation in the MR CLEAN Registry showed excellent discriminative ability for functional independence (C statistic, 0.91; 95% CI, 0.90-0.92) and survival (0.89; 95% CI, 0.88-0.90). The proportion of functional independence in the MR CLEAN Registry was systematically higher than predicted by the model (41% vs 34%), whereas observed and predicted survival were similar (72% vs 75%). The model was updated and implemented for clinical use. CONCLUSION AND RELEVANCE: The prognostic tool MR PREDICTS@24H can be applied 1 day after EVT to accurately predict functional outcome for individual patients at 90 days and to provide reliable outcome expectations and personalize follow-up and rehabilitation plans. It will need further validation and updating for contemporary patients.
- Published
- 2023
- Full Text
- View/download PDF
9. Determinants of door-in-door-out time in patients with ischaemic stroke transferred for endovascular thrombectomy
- Author
-
van de Wijdeven, Ruben M, Duvekot, Martijne HC, van der Geest, Patrick J, Moudrous, Walid, Dorresteijn, Kirsten RIS, Wijnhoud, Annemarie D, Mulder, Laus JMM, Alblas, Kees CL, Asahaad, Nabil, Kerkhoff, Henk, Dippel, Diederik WJ, and Roozenbeek, Bob
- Abstract
Background: Long door-in-door-out (DIDO) times are an important cause of treatment delay in patients transferred for endovascular thrombectomy (EVT) from primary stroke centres (PSC) to an intervention centre. Insight in causes of prolonged DIDO times may facilitate process improvement interventions. We aimed to quantify different components of DIDO time and to identify determinants of DIDO time.Methods: We performed a retrospective cohort study in a Dutch ambulance region consisting of six PSCs and one intervention centre. We included consecutive adult patients with anterior circulation large vessel occlusion, transferred from a PSC for EVT between October 1, 2019 and November 31, 2020. We subdivided DIDO into several time components and quantified contribution of these components to DIDO time. We used univariable and multivariable linear regression models to explore associations between potential determinants and DIDO time.Results: We included 133 patients. Median (IQR) DIDO time was 66 (52–83) min. The longest component was CTA-to-ambulance notification time with a median (IQR) of 24 (16–37) min. DIDO time increased with age (6 min per 10 years, 95% CI: 2–9), onset-to-door time outside 6 h (20 min, 95% CI: 5–35), M2-segment occlusion (15 min, 95% CI: 4–26) and right-sided ischaemia (12 min, 95% CI: 2–21).Conclusions: The CTA-to-ambulance notification time is the largest contributor to DIDO time. Higher age, onset-to-door time longer than 6 h, M2-segment occlusion and right-sided occlusions are independently associated with a longer DIDO time. Future interventions that aim to decrease DIDO time should take these findings into account.
- Published
- 2023
- Full Text
- View/download PDF
10. Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy
- Author
-
van den Berg, Sophie A, Uniken Venema, Simone M, LeCouffe, Natalie E, Postma, Alida A, Lycklama à Nijeholt, Geert J, Rinkel, Leon A, Treurniet, Kilian M, Kappelhof, Manon, Bruggeman, Agnetha E, van Kranendonk, Katinka R, Majoie, Charles BLM, Dippel, Diederik WJ, van der Worp, H Bart, Coutinho, Jonathan M, Nederkoorn, Paul J, and Roos, Yvo BWEM
- Abstract
Introduction: High systolic blood pressure (SBP) is associated with poor functional outcome. We analysed whether the association of SBP with outcomes after endovascular treatment (EVT) is modified by prior intravenous thrombolysis (IVT).Patients and methods: This was a post-hoc analysis of MR CLEAN-NO IV, a randomised trial of IVT with alteplase followed by EVT versus EVT alone, within 4.5 h from stroke onset. SBP was recorded on hospital admission. The primary outcome was 90-day modified Rankin Scale (mRS) score and secondary outcomes included symptomatic intracranial haemorrhage (sICH) and successful reperfusion (eTICI 2b-3), analysed with (ordinal) logistic regression. Estimates were calculated per 10 mmHg change in SBP. We assessed whether IVT modified the associations of SBP with these outcomes using multiplicative interaction terms.Results: Of 539 randomised patients, 266 received IVT. The association of SBP with mRS score was J-shaped, with an inflection point at 150 mmHg. Using 150 mmHg as a reference point, SBPs higher than 150 mmHg were associated with poor functional outcome (acOR: 1.23, 95% CI: 1.09–1.38), but lower SBPs were not (acOR: 1.14, 95% CI: 0.99–1.30). Higher SBP was not associated with the risk of sICH (aOR: 1.09, 95% CI: 0.93–1.27) nor with the probability of successful reperfusion (aOR: 1.00, 95% CI: 0.91–1.10). Our main result was that we found no effect modification by IVT (p-values for interaction, mRS = 0.94; sICH = 0.26; successful reperfusion = 0.58).Discussion and conclusion: There was no effect modification of IVT with SBP for any of the clinical outcomes. Therefore, the level of SBP (if ⩽185/110 mmHg) should not guide IVT decisions in patients otherwise eligible for both IVT and EVT within the 4.5-h time window.Trial registration: ISRCTN80619088, https://www.isrctn.com/ISRCTN80619088.
- Published
- 2023
- Full Text
- View/download PDF
11. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial
- Author
-
van der Ende, Nadinda A. M., Roozenbeek, Bob, Smagge, Lucas E. M., Luijten, Sven P. R., Aerden, Leo A. M., Kraayeveld, Petra, van den Wijngaard, Ido R., Lycklama à Nijeholt, Geert J., den Hertog, Heleen M., Flach, H. Zwenneke, Postma, Alida A., Roosendaal, Stefan D., Krietemeijer, G. Menno, Yo, Lonneke S. F., de Maat, Moniek P. M., Nieboer, Daan, Del Zoppo, Gregory J., Meurer, William J., Lingsma, Hester F., van der Lugt, Aad, and Dippel, Diederik W. J.
- Abstract
IMPORTANCE: Dual thrombolytic treatment with small bolus alteplase and mutant prourokinase has the potential to be a safer and more efficacious treatment for ischemic stroke than alteplase alone because mutant prourokinase is designed to act only on degraded fibrin without affecting circulating fibrinogen. OBJECTIVE: To assess the safety and efficacy of this dual thrombolytic treatment compared with alteplase. DESIGN, SETTING, AND PARTICIPANTS: This controlled, open-label randomized clinical trial with a blinded end point was conducted from August 10, 2019, to March 26, 2022, with a total follow-up of 30 days. Adult patients with ischemic stroke from 4 stroke centers in the Netherlands were enrolled. INTERVENTIONS: Patients were randomized (1:1) to receive a bolus of 5 mg of intravenous alteplase and 40 mg of an intravenous infusion of mutant prourokinase (intervention) or usual care with 0.9 mg/kg of intravenous alteplase (control). MAIN OUTCOMES AND MEASURES: The primary outcome was any intracranial hemorrhage (ICH) on neuroimaging at 24 hours. Secondary outcomes included functional outcome at 30 days, symptomatic ICH, and fibrinogen levels within 24 hours. Analyses were by intention to treat. Treatment effects were adjusted for baseline prognostic factors. RESULTS: A total of 268 patients were randomized, and 238 (median [IQR] age, 69 [59-77] years; 147 [61.8%] male) provided deferred consent and were included in the intention-to-treat population (121 in the intervention group and 117 in the control group). The median baseline score on the National Institutes of Health Stroke Scale was 3 (IQR, 2-5). Any ICH occurred in 16 of 121 patients (13.2%) in the intervention group and 16 of 117 patients (13.7%) in the control group (adjusted odds ratio, 0.98; 95% CI, 0.46-2.12). Mutant prourokinase led to a nonsignificant shift toward better modified Rankin Scale scores (adjusted common odds ratio, 1.16; 95% CI, 0.74-1.84). Symptomatic ICH occurred in none of the patients in the intervention group and 3 of 117 patients (2.6%) in the control group. Plasma fibrinogen levels at 1 hour remained constant in the intervention group but decreased in the control group (β = 65 mg/dL; 95% CI, 26-105 mg/dL). CONCLUSIONS AND RELEVANCE: In this trial, dual thrombolytic treatment with small bolus alteplase and mutant prourokinase was found to be safe and did not result in fibrinogen depletion. Further evaluation of thrombolytic treatment with mutant prourokinase in larger trials to improve outcomes in patients with larger ischemic strokes is needed. Overall, in patients with minor ischemic stroke who met indications for treatment with intravenous thrombolytics but were not eligible for treatment with endovascular therapy, dual thrombolytic therapy with intravenous mutant prourokinase was not superior to treatment with intravenous alteplase alone. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04256473
- Published
- 2023
- Full Text
- View/download PDF
12. Interobserver Agreement on Intracranial Hemorrhage on Magnetic Resonance Imaging in Patients With Ischemic Stroke
- Author
-
van der Ende, Nadinda A.M., Luijten, Sven P.R., Kluijtmans, Leo, Postma, Alida A., Cornelissen, Sandra A., van Hattem, Antonius M.G., Lycklama à Nijeholt, Geert J., Bokkers, Reinoud P.H., Thomassen, Lars, Waje-Andreassen, Ulrike, Logallo, Nicola, Bracard, Serge, Gory, Benjamin, Roozenbeek, Bob, Dippel, Diederik W.J., and van der Lugt, Aad
- Published
- 2023
- Full Text
- View/download PDF
13. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
- Author
-
Olthuis, Susanne G H, Pirson, F Anne V, Pinckaers, Florentina M E, Hinsenveld, Wouter H, Nieboer, Daan, Ceulemans, Angelique, Knapen, Robrecht R M M, Robbe, M M Quirien, Berkhemer, Olvert A, van Walderveen, Marianne A A, Lycklama à Nijeholt, Geert J, Uyttenboogaart, Maarten, Schonewille, Wouter J, van der Sluijs, P Matthijs, Wolff, Lennard, van Voorst, Henk, Postma, Alida A, Roosendaal, Stefan D, van der Hoorn, Anouk, Emmer, Bart J, Krietemeijer, Menno G M, van Doormaal, Pieter-Jan, Roozenbeek, Bob, Goldhoorn, Robert-Jan B, Staals, Julie, de Ridder, Inger R, van der Leij, Christiaan, Coutinho, Jonathan M, van der Worp, H Bart, Lo, Rob T H, Bokkers, Reinoud P H, van Dijk, Ewoud I, Boogaarts, Hieronymus D, Wermer, Marieke J H, van Es, Adriaan C G M, van Tuijl, Julia H, Kortman, Hans G J, Gons, Rob A R, Yo, Lonneke S F, Vos, Jan-Albert, de Laat, Karlijn F, van Dijk, Lukas C, van den Wijngaard, Ido R, Hofmeijer, Jeannette, Martens, Jasper M, Brouwers, Paul J A M, Bulut, Tomas, Remmers, Michel J M, de Jong, Thijs E A M, den Hertog, Heleen M, van Hasselt, Boudewijn A A M, Rozeman, Anouk D, Elgersma, Otto E H, van der Veen, Bas, Sudiono, Davy R, Lingsma, Hester F, Roos, Yvo B W E M, Majoie, Charles B L M, van der Lugt, Aad, Dippel, Diederik W J, van Zwam, Wim H, and van Oostenbrugge, Robert J
- Abstract
Endovascular treatment for anterior circulation ischaemic stroke is effective and safe within a 6 h window. MR CLEAN-LATE aimed to assess efficacy and safety of endovascular treatment for patients treated in the late window (6–24 h from symptom onset or last seen well) selected on the basis of the presence of collateral flow on CT angiography (CTA).
- Published
- 2023
- Full Text
- View/download PDF
14. Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke
- Author
-
van der Ende, Nadinda A.M., den Hartog, Sanne J., Broderick, Joseph P., Khatri, Pooja, Visser-Meily, Johanna M.A., van Leeuwen, Nikki, Lingsma, Hester F., Roozenbeek, Bob, and Dippel, Diederik W.J.
- Published
- 2023
- Full Text
- View/download PDF
15. Association between type of intervention center and outcomes after endovascular treatment for acute ischemic stroke: Results from the MR CLEAN Registry
- Author
-
Olthuis, Susanne GH, Hinsenveld, Wouter H, Pinckaers, Florentina ME, Amini, Marzyeh, Lingsma, Hester F, Staals, Julie, HCML Schreuder, Tobien, Schonewille, Wouter J, Yo, Lonneke SF, BWEM Roos, Yvo, Postma, Alida A, Dippel, Diederik WJ, van Zwam, Wim H, van Oostenbrugge, Robert J, and de Ridder, Inger R
- Abstract
Background: Endovascular treatment (EVT) for acute ischemic stroke (AIS) is performed in intervention centers that provide the full range of neuro(endo)vascular care (level 1) and centers that only perform EVT for AIS (level 2). We compared outcomes between these center types and assessed whether differences in outcomes could be explained by center volume (CV).Patients and methods: We analyzed patients included in the MR CLEAN Registry (2014–2018), a registry of all EVT-treated patients in the Netherlands. Our primary outcome was the shift on the modified Rankin scale (mRS) after 90 days (ordinal regression). Secondary outcomes were the NIHSS 24–48 h post-EVT, door-to-groin time (DTGT), procedure time (linear regression), and recanalization (binary logistic regression). We compared outcomes between level 1 and 2 centers using multilevel regression models, with center as random intercept. We adjusted for relevant baseline factors, and in case of observed differences, we additionally adjusted for CV.Results: Of the 5144 patients 62% were treated in level 1 centers. We observed no significant differences between center types in mRS (adjusted(a)cOR: 0.79, 95% CI: 0.40 to 1.54), NIHSS (aβ: 0.31, 95% CI: −0.52 to 1.14), procedure duration (aβ: 0.88, 95% CI: −5.21 to 6.97), or DTGT (aβ: 4.24, 95% CI: −7.09 to 15.57). The probability for recanalization was higher in level 1 centers compared to level 2 centers (aOR 1.60, 95% CI: 1.10 to 2.33), and this difference probably depended on CV.Conclusions: We found no significant differences, that were independent of CV, in the outcomes of EVT for AIS between level 1 and level 2 intervention centers.
- Published
- 2023
- Full Text
- View/download PDF
16. Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: External Validation of Prediction Models
- Author
-
van der Ende, Nadinda A.M., Kremers, Femke C.C., van der Steen, Wouter, Venema, Esmee, Kappelhof, Manon, Majoie, Charles B.L.M., Postma, Alida A., Boiten, Jelis, van den Wijngaard, Ido R., van der Lugt, Aad, Dippel, Diederik W.J., and Roozenbeek, Bob
- Published
- 2023
- Full Text
- View/download PDF
17. Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events
- Author
-
Nguyen, Thanh N., Qureshi, Muhammad M., Klein, Piers, Yamagami, Hiroshi, Mikulik, Robert, Czlonkowska, Anna, Abdalkader, Mohamad, Sedova, Petra, Sathya, Anvitha, Lo, Hannah C., Mansour, Ossama Yassin, Vanguru, Husitha Reddy, Lesaine, Emilie, Tsivgoulis, Georgios, Loochtan, Aaron I., Demeestere, Jelle, Uchino, Ken, Inoa, Violiza, Goyal, Nitin, Charidimou, Andreas, Siegler, James E., Yaghi, Shadi, Aguiar de Sousa, Diana, Mohammaden, Mahmoud H., Haussen, Diogo C., Kristoffersen, Espen Saxhaug, Lereis, Virginia Pujol, Scollo, Sergio Daniel, Campbell, Bruce C. V., Ma, Alice, Thomas, James Orton, Parsons, Mark W., Singhal, Shaloo, Slater, Lee-Anne, Tomazini Martins, Rodrigo, Enzinger, Chris, Gattringer, Thomas, Rahman, Aminur, Bonnet, Thomas, Ligot, Noemie, De Raedt, Sylvie, Lemmens, Robin, Vanacker, Peter, Vandervorst, Fenne, Conforto, Adriana Bastos, Hidalgo, Raquel C.T., de Oliveira Neves, Luciana, Martins, Rodrigo Targa, Mora Cuervo, Daissy Liliana, Rebello, Leticia C., Santiago, Igor Bessa, Lameirinhas da Silva, Isabelle, Sakelarova, Teodora, Kalpachki, Rosen, Alexiev, Filip, Catanese, Luciana, Cora, Elena Adela, Goyal, Mayank, Hill, Michael D., Kelly, Michael E., Khosravani, Houman, Lavoie, Pascale, Peeling, Lissa, Pikula, Aleksandra, Rivera, Rodrigo, Chen, Hui-Sheng, Chen, Yimin, Huo, Xiaochuan, Miao, Zhongrong, Yang, Shuiquan, Bedekovic, Marina Roje, Bralic, Marina, Budincevic, Hrvoje, Corredor-Quintero, Angel Basilio, Lara-Sarabia, Osvaldo E., Cabal, Martin, Tenora, Dusan, Fibrich, Petr, Herzig, Roman, Hlaváčová, Helena, Hrabanovska, Emanuela, Hlinovsky, David, Jurak, Lubomir, Kadlcikova, Jana, Karpowicz, Igor, Klecka, Lukas, Kovar, Martin, Lauer, David, Neumann, Jiri, Palouskova, Hana, Reiser, Martin, Rekova, Petra, Rohan, Vladimir, Skoda, Ondrej, Škorňa, Miroslav, Sobotková, Lenka, Sramek, Martin, Zakova, Lenka, Christensen, Hanne, Drenck, Nicolas, Iversen, Helle Klingenberg, Truelsen, Thomas Clement, Wienecke, Troels, Sobh, Khalid, Ylikotila, Pauli, Alpay, Kemal, Strbian, Daniel, Bernady, Patricia, Casenave, Philippe, Dan, Maria, Faucheux, Jean-Marc, Gentric, Jean-Christophe, Magro, Elsa, Sabben, Candice, Reiner, Peggy, Rouanet, Francois, Bohmann, Ferdinand O., Boskamp, Stefan, Mbroh, Joshua, Nagel, Simon, Nolte, Christian H., Ringleb, Peter A., Rosenkranz, Michael, Poli, Sven, Thomalla, Götz, Karapanayiotides, Theodoros, Koutroulou, Ioanna, Kargiotis, Odysseas, Palaiodimou, Lina, Barrientos Guerra, Jose Dominguo, Huded, Vikram, Menon, Bindu, Nagendra, Shashank, Prajapati, Chintan, Sylaja, P.N., Krishna Pramana, Nyoman Angga, Sani, Achmad Firdaus, Ghoreishi, Abdoreza, Farhoudi, Mehdi, Hokmabadi, Elyar Sadeghi, Raya, Tariq Abu, Kalmanovich, Shani Avnery, Ronen, Levite, Sabetay, Sergiu Ionut, Acampa, Maurizio, Adami, Alessandro, Castellan, Lucio, Longoni, Marco, Ornello, Raffaele, Renieri, Leonardo, Bigliani, Claudia Rolla, Romoli, Michele, Sacco, Simona, Salmaggi, Andrea, Sangalli, Davide, Zini, Andrea, Doijiri, Ryosuke, Fukuda, Hiroki, Fujinaka, Toshiyuki, Fujita, Kyohei, Imamura, Hirotoshi, Sakai, Nobuyuki, Kanamaru, Takuya, Kimura, Naoto, Kono, Ryuhei, Miyake, Kosuke, Sakaguchi, Manabu, Sakai, Kenichiro, Sonoda, Kazutaka, Todo, Kenichi, Miyashita, Fumio, Tokuda, Naoki, Matsumaru, Yuji, Matsumoto, Shoji, Ohara, Nobuyuki, Shindo, Seigo, Takenobu, Yohei, Yoshimoto, Takeshi, Toyoda, Kazunori, Uwatoko, Takeshi, Yagita, Yoshiki, Yamada, Takehiro, Yamamoto, Nobuaki, Yamamoto, Ryoo, Yazawa, Yukako, Sugiura, Yuri, Waweru, Peter Kuria, Baek, Jang-Hyun, Lee, Si Baek, Seo, Kwon-Duk, Sohn, Sung-Il, Arsovska, Anita Ante, Chan, Yong Chieh, Wan Zaidi, Wan Asyraf, Jaafar, Ainul Syahrilfazli, Gongora-Rivera, Fernando, Martinez-Marino, Manuel, Infante-Valenzuela, Adrian, Groppa, Stanislav, Leahu, Pavel, Coutinho, Jonathan M., Rinkel, Leon A., Dippel, Diederik W.J., van Dam-Nolen, Dianne H.K., Ranta, Annemarei, Wu, Teddy Y., Adebayo, Tajudeen Temitayo, Bello, Abiodun H., Nwazor, Ernest Okwundu, Sunmonu, Taofiki Ajao, Wahab, Kolawole Wasiu, Ronning, Ole Morten, Sandset, Else Charlotte, Al Hashmi, Amal M., Ahmad, Saima, Rashid, Umair, Rodriguez-Kadota, Liliana, Vences, Miguel Ángel, Yalung, Patrick Matic, Hao Dy, Jon Stewart, Pineda-Franks, Maria Carissa, Co, Christian Oliver, Brola, Waldemar, Debiec, Aleksander, Dorobek, Malgorzata, Karlinski, Michal Adam, Labuz-Roszak, Beata M., Lasek-Bal, Anetta, Sienkiewicz-Jarosz, Halina, Staszewski, Jacek, Sobolewski, Piotr, Wiacek, Marcin, Zielinska-Turek, Justyna, Araujo, Andre Pinho, Rocha, Mariana, Castro, Pedro, Cruz, Vitor Tedim, Ferreira, Paulo Venancio, Ferreira, Patricia, Nunes, Ana Paiva, Fonseca, Luisa, Marto, João Pedro, Pinho e Melo, Teresa, Rodrigues, Miguel, Silva, M. Luis, Dimitriade, Adela, Falup-Pecurariu, Cristian, Hamid, May Adel, Venketasubramanian, Narayanaswamy, Krastev, Georgi, Mako, Miroslav, Ayo-Martin, Oscar, Hernández-Fernández, Francisco, Blasco, Jordi, Rodríguez-Vázquez, Alejandro, Cruz-Culebras, Antonio, Moniche, Francisco, Montaner, Joan, Perez-Sanchez, Soledad, García Sánchez, María Jesús, Guillán Rodríguez, Marta, Jood, Katarina, Nordanstig, Annika, Mazya, Michael V., Moreira, Tiago T.P., Bernava, Gianmarco, Beyeler, Morin, Bolognese, Manuel, Carrera, Emmanuel, Dobrocky, Tomas, Karwacki, Grzegorz Marek, Keller, Emanuela, Hsieh, Chang Yang, Boonyakarnkul, Surawan, Churojana, Anchalee, Aykac, Ozlem, Ozdemir, Atilla Özcan, Bajrami, Arsida, Senadim, Songul, Hussain, Syed Irteza, John, Seby, Banerjee, Soma, Kwan, Joseph, Krishnan, Kailash, Lenthall, Robert, Matthews, Ashok, Wong, Ken, Zhang, Liqun, Altschul, Dorothea, Asif, Kaiz S., Bahiru, Zeelalem, Below, Kristine, Biller, José, Ruland, Sean, Chaudry, Saqib A., Chen, Michael, Chebl, Alex, Cibulka, Jackie, Cistrunk, Leon, Clark, Judith, Colasurdo, Marco, Czap, Alexandra, de Havenon, Adam, D'Amato, Salvatore, Dharmadhikari, Sushrut, Grimmett, Kasey B., Dmytriw, Adam A., Etherton, Mark R., Ezepue, Chizoba, Farooqui, Mudassir, Feske, Steven K., Fink, Lauren, Gasimova, Ulviyya, Guzik, Amy K., Hakemi, Maryam, Hovingh, Majesta, Khan, Muhib, Jillela, Dinesh, Kan, Peter T., Khatri, Rakesh, Khawaja, Ayaz M., Khoury, Naim N., Kiley, Nicole L., Kim, Benny S., Kolikonda, Murali K., Kuhn, Anna Luisa, Lara, Stephanie, Linares, Guillermo, Linfante, Italo, Lukovits, Timothy G., Lycan, Sarah, Male, Shailesh S., Maali, Laith, Mancin, John, Masoud, Hesham, Mohamed, Ghada A., Monteiro, Andre, Nahab, Fadi, Nalleballe, Krishna, Ortega-Gutierrez, Santiago, Puri, Ajit S., Radaideh, Yazan, Rahangdale, Rahul H., Rai, Ansaar, Ramakrishnan, Pankajavalli, Reddy, Aravind B., Rojas-Soto, Diana M., Romero, Jose Rafael, Rost, Natalia S., Rothstein, Aaron, Omran, Setareh Salehi, Sheth, Sunil A., Siddiqui, Adnan H., Starosciak, Amy K., Tarlov, Nicholas E., Taylor, Robert A., Wang, Michael J., Wolfe, Jared, Wong, Ka-Ho, Le, Huynh Vu, Nguyen, Quy Viet, Pham, Thong Nhu, Nguyen, Trung Thanh, Phan, Hoang Thi, Ton, Mai Duy, Fischer, Urs, Michel, Patrik, Strambo, Davide, Martins, Sheila O., Zaidat, Osama O., and Nogueira, Raul G.
- Published
- 2023
- Full Text
- View/download PDF
18. Clinical outcome of patients with mild pre-stroke morbidity following endovascular treatment: a HERMES substudy
- Author
-
McDonough, Rosalie V, Ospel, Johanna M, Majoie, Charles B L M, Saver, Jeffrey L, White, Philip, Dippel, Diederik W J, Brown, Scott B, Demchuk, Andrew M, Jovin, Tudor G, Mitchell, Peter J, Bracard, Serge, Campbell, Bruce C V, Muir, Keith W, Hill, Michael D, Guillemin, Francis, and Goyal, Mayank
- Abstract
BackgroundAnalyses of the effect of pre-stroke functional levels on the outcome of endovascular therapy (EVT) have focused on the course of patients with moderate to substantial pre-stroke disability. The effect of complete freedom from pre-existing disability (modified Rankin Scale (mRS) 0) versus predominantly mild pre-existing disability/symptoms (mRS 1–2) has not been well delineated.MethodsThe HERMES meta-analysis pooled data from seven randomized trials that tested the efficacy of EVT. We tested for a multiplicative interaction effect of pre-stroke mRS on the relationship between treatment and outcomes. Ordinal regression was used to assess the association between EVT and 90-day mRS (primary outcome) in the subgroup of patients with pre-stroke mRS 1–2. Multivariable regression modeling was then used to test the effect of mild pre-stroke disability/symptoms on the primary and secondary outcomes (delta-mRS, mRS 0–2/5–6) compared with patients with pre-stroke mRS 0.ResultsWe included 1764 patients, of whom 199 (11.3%) had pre-stroke mRS 1–2. No interaction effect of pre-stroke mRS on the relationship between treatment and outcome was observed. Patients with pre-stroke mRS 1–2 had worse outcomes than those with pre-stroke mRS 0 (adjusted common OR (acOR) 0.53, 95% CI 0.40 to 0.70). Nonetheless, a significant benefit of EVT was observed within the mRS 1–2 subgroup (cOR 2.08, 95% CI 1.22 to 3.55).ConclusionsPatients asymptomatic/without disability prior to onset have better outcomes following EVT than patients with mild disability/symptoms. Patients with pre-stroke mRS 1–2, however, more often achieve good outcomes with EVT compared with conservative management. These findings indicate that mild pre-existing disability/symptoms influence patient prognosis after EVT but do not diminish the EVT treatment effect.
- Published
- 2023
- Full Text
- View/download PDF
19. Risk factors of unexplained early neurological deterioration after treatment for ischemic stroke due to large vessel occlusion: a post hoc analysis of the HERMES study
- Author
-
Bourcier, Romain, Goyal, Mayank, Muir, Keith W, Desal, Hubert, Dippel, Diederik W J, Majoie, Charles B L M, van Zwam, Wim H, Jovin, Tudor G, Mitchell, Peter J, Demchuk, Andrew M, van Oostenbrugge, Robert J, Brown, Scott B, Campbell, Bruce, White, Philip, Hill, Michael D, Saver, Jeffrey L, Weimar, Christian, Jahan, Reza, Guillemin, Francis, Bracard, Serge, and Naggara, Olivier
- Abstract
BackgroundEarly neurological deterioration (END) after endovascular treatment (EVT) in patients with anterior circulation acute ischemic stroke (AIS) is associated with poor outcome. END may remain unexplained by parenchymal hemorrhage (UnEND). We aim to analyze the risk factors of UnEND in the medical management (MM) and EVT arms of the HERMES study.MethodsWe conducted a post-hoc analysis of anterior AIS patients who underwent EVT for proximal anterior occlusions. Risk factors of UnEND, defined as a worsening of ≥4 points between baseline National Institutes of Health Stroke Scale (NIHSS) and NIHSS at 24 hours without hemorrhage, were compared between both arms using mixed logistic regression models adjusted for baseline characteristics. An interaction analysis between the EVT and MM arms for risk factors of UnEND was conducted.ResultsAmong 1723 patients assessable for UnEND, 160 patients experienced an UnEND (9.3%), including 9.1% (78/854) in the EVT arm and 9.4% (82/869) in the MM arm. There was no significant difference in the incidence of UnEND between the two study arms. In the EVT population, independent risk factors of UnEND were lower baseline NIHSS, higher baseline glucose, and lower collateral grade. In the MM population, the only independent predictor of UnEND was higher baseline glucose. However, we did not demonstrate an interaction between EVT and MM for baseline factors as risk factors of UnEND. UnEND was, similarly in both treatment groups, a significant predictor of unfavorable outcome in both the EVT (p<0.001) and MM (p<0.001) arms.ConclusionsUnEND is not an uncommon event, with a similar rate which ever treatment arm is considered. In the clinical scenario of AIS due to large vessel occlusion, no patient-related factor seems to increase the risk for UnEND when treated by EVT compared with MM.
- Published
- 2023
- Full Text
- View/download PDF
20. Sex differences in onset to hospital arrival time, prestroke disability, and clinical symptoms in patients with a large vessel occlusion: a MR CLEAN Registry substudy
- Author
-
Ali, Mariam, van der Meij, Anne, van Os, Hendrikus J A, Ali, Mahsoem, Van Zwet, Erik W, Spaander, Fianne H M, Hofmeijer, Jeanette, Nederkoorn, Paul J, van den Wijngaard, Ido R, Majoie, Charles B L M, van Es, Adriaan C G M, Schonewille, Wouter J, van Walderveen, Marianne A A, Dippel, Diederik W J, Visser, Marieke C, Kruyt, Nyika D, and Wermer, Marieke J H
- Abstract
BackgroundWomen have been reported to have worse outcomes after endovascular treatment (EVT), despite a similar treatment effect in non-clinical trial populations. We aimed to assess sex differences at hospital presentation with respect to workflow metrics, prestroke disability, and presenting clinical symptoms.MethodsWe included consecutive patients from the Multicentre Randomised Controlled Trial of Endovascular Treatment for Acute Ischaemic Stroke in The Netherlands (MR CLEAN) Registry (2014–2018) who received EVT for anterior circulation large vessel occlusion (LVO). We assessed sex differences in workflow metrics, prestroke disability (modified Rankin Scale (mRS) score ≥1), and stroke severity and symptoms according to the National Institutes of Health Stroke Scale (NIHSS) score on hospital admission with logistic and linear regression analyses and calculated the adjusted OR (aOR).ResultsWe included 4872 patients (47.6% women). Compared with men, women were older (median age 76 vs 70 years) and less often achieved good functional outcome at 90 days (mRS ≤2: 35.2% vs 46.4%, aOR 0.70, 95% CI 0.60 to 0.82). Mean onset-to-door time was longer in women (2 hours 16 min vs 2 hours 7 min, adjusted delay 9 min, 95% CI 4 to 13). This delay contributed to longer onset-to-groin times (3 hours 26 min in women vs 3 hours 13 min in men, adjusted delay 13 min, 95% CI 9 to 17). Women more often had prestroke disability (mRS ≥1: 41.1% vs 29.1%, aOR 1.57, 95% CI 1.36 to 1.82). NIHSS on admission was essentially similar in men and women (mean 15±6 vs 15±6, NIHSS <10 vs ≥10, aOR 0.91, 95% CI 0.78 to 1.06). There were no clear sex differences in the occurrence of specific stroke symptoms.ConclusionWomen with LVO had longer onset-to-door times and more often prestroke disability than men. Raising awareness of these differences at hospital presentation and investigating underlying causes may help to improve outcome after EVT in women.
- Published
- 2023
- Full Text
- View/download PDF
21. Hemorrhage rates in patients with acute ischemic stroke treated with intravenous alteplase and thrombectomy versus thrombectomy alone
- Author
-
van Kranendonk, Katinka R, Kappelhof, Manon, Bruggeman, Agnetha A E, Rinkel, Leon A, Treurniet, Kilian M, LeCouffe, Natalie, Emmer, Bart J, Coutinho, Jonathan M, Wolff, Lennard, van Zwam, Wim H, van Oostenbrugge, Robert J, van der Lugt, Aad, Dippel, Diederik W J, Roos, Yvo B W E M, Marquering, Henk A, and Majoie, Charles B L M
- Abstract
BackgroundIntravenous alteplase treatment (IVT) for acute ischemic stroke carries a risk of intracranial hemorrhage (ICH). However, reperfusion of an occluded vessel itself may contribute to the risk of ICH. We determined whether IVT and reperfusion are associated with ICH or its volume in the Multicenter Randomized Clinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN)-NO IV trial.MethodsThe MR CLEAN-NO IV trial randomized patients with acute ischemic stroke due to large vessel occlusion to receive either IVT followed by endovascular treatment (EVT) or EVT alone. ICH was classified according to the Heidelberg bleeding classification on follow-up MRI or CT approximately 8 hours−7 days after stroke. Hemorrhage volume was measured with ITK-snap. Successful reperfusion was defined as extended Thrombolysis In Cerebral Infarction (eTICI) score of 2b-3. Multinomial and binary adjusted logistic regression were used to determine the association of IVT and reperfusion with ICH subtypes.ResultsOf 539 included patients, 173 (32%) developed ICH and 30 suffered from symptomatic ICH (sICH) (6%). Of the patients with ICH, 102 had hemorrhagic infarction, 47 had parenchymal hematoma, 44 had SAH, and six had other ICH. Reperfusion was associated with a decreased risk of SAH, and IVT was not associated with SAH (eTICI 2b-3: adjusted OR 0.45, 95% CI 0.21 to 0.97; EVT without IVT: OR 1.6, 95% CI 0.91 to 2.8). Reperfusion status and IVT were not associated with overall ICH, hemorrhage volume, and sICH (sICH: EVT without IVT, OR 0.96, 95% CI 0.41 to 2.25; eTICI 2b-3, OR 0.49, 95% CI 0.23 to 1.05).ConclusionNeither IVT administration before EVT nor successful reperfusion after EVT were associated with ICH, hemorrhage volume, and sICH. SAH occurred more often in patients for whom successful reperfusion was not achieved.
- Published
- 2023
- Full Text
- View/download PDF
22. Successful reperfusion in relation to the number of passes: comparing outcomes of first pass expanded Treatment In Cerebral Ischemia (eTICI) 2B with multiple-pass eTICI 3
- Author
-
Bruggeman, Agnetha A E, Kappelhof, Manon, den Hartog, Sanne J, Burke, James F, Berkhemer, Olvert A, van Es, Adriaan C G M, van Zwam, Wim H, Dippel, Diederik W J, Coutinho, Jonathan M, Marquering, Henk A, Majoie, Charles B L M, and Emmer, Bart J
- Abstract
BackgroundHigher expanded Treatment In Cerebral Ischemia (eTICI) reperfusion scores after endovascular treatment (EVT) are associated with better outcomes. However, the influence of the number of passes on this association is unclear. We aimed to compare outcomes of single-pass good reperfusion (eTICI 2B) with multiple-pass excellent/complete reperfusion (eTICI 2C/3) in daily clinical practice.MethodsWe compared outcomes of patients in the MR CLEAN Registry with good reperfusion (eTICI 2B) in a single pass to those with excellent/complete reperfusion (eTICI 2C/3) in multiple passes. Regression models were used to investigate the association of single-pass eTICI 2B versus multiple-pass eTICI 2C/3 reperfusion with 90-day functional outcome (modified Rankin Scale (mRS)), functional independence (mRS 0–2), per-procedural complications and safety outcomes.ResultsWe included 699 patients: 178 patients with single-pass eTICI 2B, and 242 and 279 patients with eTICI 2C/3 after 2 and ≥3 passes, respectively. Patients with eTICI 2C/3 after 2 or ≥3 passes did not achieve significantly better functional outcomes compared with patients with single-pass eTICI 2B (adjusted common OR (acOR) 1.06, 95% CI 0.75 to 1.50 and acOR 0.88, 95% CI 0.74 to 1.05 for 90-day mRS, and adjusted OR (aOR) 1.24, 95% CI 0.78 to 1.97 and aOR 0.79, 95% CI 0.52 to 1.22 for functional independence).ConclusionsOur results did not show better outcomes for patients who achieved eTICI 2C/3 in multiple, that is, two or more, passes when compared with patients with single-pass eTICI 2B. However, this concerns observational data. Further research is necessary to investigate the per-pass effect in relation to reperfusion and functional outcome.
- Published
- 2023
- Full Text
- View/download PDF
23. Influence of the interventionist’s experience on outcomes of endovascular thrombectomy in acute ischemic stroke: results from the MR CLEAN Registry
- Author
-
Olthuis, Susanne G H, den Hartog, Sanne J, van Kuijk, Sander M J, Staals, Julie, Benali, Faysal, van der Leij, Christiaan, Beumer, Debbie, Lycklama à Nijeholt, Geert J, Uyttenboogaart, Maarten, Martens, Jasper M, van Doormaal, Pieter-Jan, Vos, Jan Albert, Emmer, Bart J, Dippel, Diederik W J, van Zwam, Wim H, van Oostenbrugge, Robert J, and de Ridder, Inger R
- Abstract
BackgroundThe relationship between the interventionist’s experience and outcomes of endovascular thrombectomy (EVT) for acute ischemic stroke of the anterior circulation, is unclear.ObjectiveTo assess the effect of the interventionist’s level of experience on clinical, imaging, and workflow outcomes. Secondly, to determine which of the three experience definitions is most strongly associated with these outcome measures.MethodsWe analysed data from 2700 patients, included in the MR CLEAN Registry. We defined interventionist’s experience as the number of procedures performed in the year preceding the intervention (EXPfreq), total number of procedures performed (EXPno), and years of experience (EXPyears). Our outcomes were the baseline-adjusted National Institutes of Health Stroke Scale (NIHSS) score at 24–48 hours post-EVT, recanalization (extended Thrombolysis in Cerebral Infarction (eTICI) score ≥2B), and procedural duration. We used multilevel regression models with interventionists as random intercept. For EXPfreq and EXPno results were expressed per 10 procedures.ResultsIncreased EXPfreq was associated with lower 24–48 hour NIHSS scores (adjusted (a)β:−0.46, 95% CI −0.70 to −0.21). EXPno and EXPyears were not associated with short-term neurological outcomes. Increased EXPfreq and EXPno were both associated with recanalization (aOR=1.20, 95% CI 1.11 to 1.31 and aOR=1.08, 95% CI 1.04 to 1.12, respectively), and increased EXPfreq, EXPno, and EXPyears were all associated with shorter procedure times (aβ:−3.08, 95% CI−4.32 to −1.84; aβ:−1.34, 95% CI−1.84 to −0.85; and aβ:−0.79, 95% CI−1.45 to −0.13, respectively).ConclusionsHigher levels of interventionist’s experience are associated with better outcomes after EVT, in particular when experience is defined as the number of patients treated in the preceding year. Every 20 procedures more per year is associated with approximately one NIHSS score point decrease, an increased probability for recanalization (aOR=1.44), and a 6-minute shorter procedure time.
- Published
- 2023
- Full Text
- View/download PDF
24. Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome
- Author
-
van der Steen, Wouter, van der Ende, Nadinda A M, Luijten, Sven P R, Rinkel, Leon A, van Kranendonk, Katinka R, van Voorst, Henk, Roosendaal, Stefan D, Beenen, Ludo F M, Coutinho, Jonathan M, Emmer, Bart J, van Oostenbrugge, Robert J, Majoie, Charles B L.M, Lingsma, Hester F, van der Lugt, Aad, Dippel, Diederik W J, and Roozenbeek, Bob
- Abstract
BackgroundIntracranial hemorrhage (ICH) is a frequent complication after endovascular stroke treatment.ObjectiveTo assess the association of the occurrence and type of ICH after endovascular treatment (EVT) with functional outcome.MethodsWe analyzed data from the MR CLEAN-NO IV and MR CLEAN-MED trials. Both trials included adult patients with ischemic stroke with a large vessel occlusion in the anterior circulation, who were eligible for EVT. ICH was classified (1) as asymptomatic or symptomatic (concomitant neurological deterioration of ≥4 points on the NIHSS, or ≥2 points on 1 NIHSS item), and (2) according to the Heidelberg Bleeding Classification. We used multivariable ordinal logistic regression analyses to assess the association of the occurrence and type of ICH with the modified Rankin Scale score at 90 days.ResultsOf 1017 included patients, 331 (33%) had an asymptomatic ICH, and 90 (9%) had a symptomatic ICH. Compared with no ICH, both asymptomatic (adjusted common OR (acOR)=0.76; 95% CI 0.58 to 0.98) and symptomatic (acOR=0.07; 95% CI 0.04 to 0.14) ICH were associated with worse functional outcome. In particular, isolated parenchymal hematoma type 2 (acOR=0.37; 95% CI 0.14 to 0.95), combined parenchymal hematoma with hemorrhage outside infarcted brain tissue (acOR=0.17; 95% CI 0.10 to 0.30), and combined hemorrhages outside infarcted brain tissue (acOR=0.14; 95% CI 0.03 to 0.74) were associated with worse functional outcome than no ICH.Strength of the association of ICH with functional outcome depends on the type of ICH. Although the association is stronger for symptomatic ICH, asymptomatic ICH after EVT is also associated with worse functional outcome.
- Published
- 2023
- Full Text
- View/download PDF
25. Bifurcation occlusions and endovascular treatment outcome in acute ischemic stroke
- Author
-
Arrarte Terreros, Nerea, Bruggeman, Agnetha A E, van Voorst, Henk, Konduri, Praneeta R, Jansen, Ivo G H, Kappelhof, Manon, Tolhuisen, Manon L, Boodt, Nikki, Dippel, Diederik W J, van der Lugt, Aad, van Zwam, Wim H, van Oostenbrugge, Robert J, van der Worp, H. Bart, Emmer, Bart J, Meijer, Frederick J A, Roos, Yvo B W E M, van Bavel, Ed, Marquering, Henk A, and Majoie, Charles B L M
- Abstract
BackgroundA thrombus in the M1 segment of the middle cerebral artery (MCA) can occlude this main stem only or extend into the M1-M2 bifurcation. The occlusion pattern may affect endovascular treatment (EVT) success, as a bifurcated thrombus may be more prone to fragmentation during retrieval.ObjectiveTo investigate whether bifurcated thrombus patterns are associated with EVT procedural and clinical outcomes.MethodsOcclusion patterns of MCA thrombi on CT angiography from MR CLEAN Registry patients were classified into three groups: main stem occlusion, bifurcation occlusion extending into one M2 branch, and bifurcation occlusion extending into both M2 branches. Procedural parameters, procedural outcomes (reperfusion grade and embolization to new territory), and clinical outcomes (24-48 hour National Institutes of Health Stroke Scale [NIHSSFU] score, change in NIHSS scores between 24 and 48 hours and baseline [Formula][NIHSS], and 90-day modified Rankin Scale [mRS] scores) were compared between occlusion patterns.ResultsWe identified 1023 patients with an MCA occlusion of whom 370 (36%) had a main stem occlusion, 151 (15%) a single branch, and 502 (49%) a double branch bifurcation occlusion. There were no statistically significant differences in retrieval method, procedure time, number of retrieval attempts, reperfusion grade, and embolization to new territory between occlusion patterns. Patients with main stem occlusions had lower NIHSSFUscores than patients with single (7 vs 11, p=0.01) or double branch occlusions (7 vs 9, p=0.04). However, there were no statistically significant differences in [Formula]NIHSS or in 90-day mRS scores.ConclusionsIn our population, EVT procedural and long-term clinical outcomes were similar for MCA bifurcation occlusions and MCA main stem occlusions.
- Published
- 2023
- Full Text
- View/download PDF
26. Endovascular treatment for isolated posterior cerebral artery occlusion stroke in the MR CLEAN registry
- Author
-
Brouwer, Josje, Ergezen, Saliha, Mulder, Maxim Johan Heymen Laurence, Lycklama a Nijeholt, Geert J, van Es, Adriaan C G M, van der Lugt, Aad, Dippel, Diederik W J, Majoie, Charles B L M, Roos, Yvo B W E M, Coutinho, J M, and Emmer, Bart J
- Abstract
BackgroundEndovascular treatment (EVT) is standard of care in anterior circulation large vessel occlusions. In posterior circulation occlusions, data on EVT in isolated posterior cerebral artery (PCA) occlusions are limited, although PCA occlusions can cause severe neurological deficit.ObjectiveTo describe in a prospective study the clinical manifestations, outcomes, and safety of EVT in isolated PCA occlusions.MethodsWe used data (2014–2017) from the MR CLEAN Registry, a nationwide, prospective cohort of EVT-treated patients in the Netherlands. We included patients with acute ischemic stroke (AIS) due to an isolated PCA occlusion on CT angiography. Patients with concurrent occlusion of the basilar artery were excluded. Outcomes included change in National Institutes of Health Stroke Scale (ΔNIHSS) score, modified Rankin Scale (mRS) score 0–3 after 90 days, mortality, expanded Thrombolysis in Cerebral Infarction (eTICI), and periprocedural complications.ResultsTwenty (12%) of 162 patients with posterior circulation occlusions had an isolated PCA occlusion. Median age was 72 years; 13 (65%) were women. Median baseline NIHSS score was 13 (IQR 5–21). Six (30%) patients were comatose. Twelve patients (60%) received IVT. Median ΔNIHSS was −4 (IQR −11–+1). At follow-up, nine patients (45%) had mRS score 0–3. Seven (35%) died. eTICI 2b-3 was achieved in 13 patients (65%). Nine patients (45%) had periprocedural complications. No symptomatic intracranial hemorrhages (sICH) occurred.ConclusionsEVT should be considered in selected patients with AIS with an isolated PCA occlusion, presenting with moderate–severe neurological deficits, as EVT was technically feasible in most of our patients and about half had good clinical outcome. In case of lower NIHSS score, a more conservative approach seems warranted, since periprocedural complications are not uncommon. Nonetheless, EVT seems reasonably safe considering the absence of sICH in our study.
- Published
- 2023
- Full Text
- View/download PDF
27. Collateral status and recanalization after endovascular treatment for acute ischemic stroke
- Author
-
Uniken Venema, Simone M, Dankbaar, Jan Willem, Wolff, Lennard, van Es, Adriaan C G M, Sprengers, Marieke, van der Lugt, Aad, Dippel, Diederik W J, and van der Worp, H. Bart
- Abstract
BackgroundSuccessful recanalization and good collateral status are associated with good clinical outcomes after endovascular treatment (EVT) for acute ischemic stroke, but the relationships among them are unclear.ObjectiveTo assess if collateral status is associated with recanalization after EVT and if collateral status modifies the association between successful recanalization and functional outcome.MethodsWe retrospectively analyzed data from the MR CLEAN Registry, a multicenter prospective cohort study of patients with a proximal anterior occlusion who underwent EVT in the Netherlands. We determined collateral status with a previously validated four-point visual grading scale and defined successful recanalization as an extended Thrombolysis in Cerebral Infarction score ≥2B. Functional outcome was determined using the modified Rankin Scale score at 90 days. We assessed, with multivariable logistic regression models, the associations between (1) collateral status and successful recanalization, (2) successful recanalization and functional outcome, (3) collateral status and functional outcome. An interaction of collateral status and successful recanalization was assessed. Subgroup analyses were performed for patients treated with intravenous thrombolysis.ResultsWe included 2717 patients, of whom 1898 (70%) had successful recanalization. There was no relationship between collateral status and successful recanalization (adjusted common OR (95% CI) of grades 1, 2, and 3 vs 0: 1.19 (0.82 to 1.72), 1.20 (0.83 to 1.75), and 1.10 (0.74 to 1.63), respectively). Successful recanalization (acOR (95% CI): 2.15 (1.84 to 2.52)) and better collateral grades (acOR (95% CI) of grades 1, 2, and 3 vs 0: 2.12 (1.47 to 3.05), 3.46 (2.43 to 4.92), and 4.16 (2.89 to 5.99), respectively) were both associated with a shift towards better functional outcome, without an interaction between collateral status and successful recanalization. Results were similar for the subgroup of thrombolysed patients.ConclusionsCollateral status is not associated with the probability of successful recanalization after EVT and does not modify the association between successful recanalization and functional outcome.
- Published
- 2023
- Full Text
- View/download PDF
28. Clinical Outcome After Endovascular Treatment in Patients With Active Cancer and Ischemic Stroke
- Author
-
Verschoof, Merelijne A., Groot, Adrien E., de Bruijn, Sebastiaan F.T.M., Roozenbeek, Bob, van der Worp, H. Bart, Dippel, Diederik W.J., Emmer, Bart J., Roosendaal, Stefan D., Majoie, Charles B.L.M., Roos, Yvo B.W.E.M., Coutinho, Jonathan M., Dippel, Diederik W.J., van der Lugt, Aad, Majoie, Charles B.L.M., Roos, Yvo B.W.E.M., van Oostenbrugge, Robert J., van Zwam, Wim H., Boiten, Jelis, Vos, Jan Albert, Jansen, Ivo G.H., Mulder, Maxim J.H.L., Goldhoorn, Robert-Jan B., Schonewille, Wouter J., Coutinho, Jonathan M., Wermer, Marieke J.H., van Walderveen, Marianne A.A., Staals, Julie, Hofmeijer, Jeannette, Martens, Jasper M., Lycklama à Nijeholt, Geert J., Roozenbeek, Bob, Emmer, Bart J., de Bruijn, Sebastiaan F., van Dijk, Lukas C., Bart van der Worp, H., Lo, Rob H., van Dijk, Ewoud J., Boogaarts, Hieronymus D., de Kort, Paul L.M., Peluso, Jo J.P., van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Uyttenboogaart, Maarten, Eshghi, Omid, Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Yo, Lonneke S.F., den Hertog, Heleen M., Sturm, Emiel J.C., Sprengers, Marieke E.S., Jenniskens, Sjoerd F.M., van den Berg, René, Yoo, Albert J., Beenen, Ludo F.M., Postma, Alida A., Roosendaal, Stefan D., van der Kallen, Bas F.W., van den Wijngaard, Ido R., van Es, Adriaan C.G.M., Bot, Joost, Doormaal, Pieter-Jan van, Flach, H. Zwenneke, Lingsma, Hester F., Ghannouti, Naziha el, Ghannouti, Naziha el, Puppels, Corina, Pellikaan, Wilma, Sprengers, Rita, Sprengers, Rita, de Meris, Joke, Vermeulen, Tamara, Geerlings, Annet, van Vemde, Gina, Simons, Tiny, van Rijswijk, Cathelijn, Messchendorp, Gert, Bongenaar, Hester, Bodde, Karin, Kleijn, Sandra, Lodico, Jasmijn, Droste, Hanneke, Wollaert, M., Jeurrissen, D., Bos, Erna, Drabbe, Yvonne, Zweedijk, Berber, Khalilzada, Mostafa, Venema, Esmee, Chalos, Vicky, Compagne, Kars C.J., Geuskens, Ralph R., van Straaten, Tim, Ergezen, Saliha, Harmsma, Roger R.M., Muijres, Daan, de Jong, Anouk, Hinsenveld, Wouter, Berkhemer, Olvert A., Boers, Anna M.M., Huguet, J., Groot, P.F.C., Mens, Marieke A., van Kranendonk, Katinka R., van Kranendonk, Katinka R., Kappelhof, Manon, Tolhuijsen, Manon L., and Alves, Heitor
- Published
- 2022
- Full Text
- View/download PDF
29. Comparison of Three Scores of Collateral Status for Their Association With Clinical Outcome: The HERMES Collaboration
- Author
-
Gensicke, Henrik, Al-Ajlan, Fahad, Fladt, Joachim, Campbell, Bruce C.V., Majoie, Charles B.L.M., Bracard, Serge, Hill, Michael D., Muir, Keith W., Demchuk, Andrew, San Román, Luis, van der Lugt, Aad, Liebeskind, David S., Brown, Scott, White, Philip M., Guillemin, Francis, Dávalos, Antoni, Jovin, Tudor G., Saver, Jeffrey L., Dippel, Diederik W.J., Goyal, Mayank, Mitchell, Peter J., and Menon, Bijoy K.
- Published
- 2022
- Full Text
- View/download PDF
30. Evaluating the Diagnostic Performance of Prehospital Stroke Scales Across the Range of Deficit Severity: Analysis of the Prehospital Triage of Patients With Suspected Stroke Study
- Author
-
Ganesh, Aravind, van de Wijdeven, Ruben M., Ospel, Johanna M., Duvekot, Martijne H.C., Venema, Esmee, Rozeman, Anouk D., Moudrous, Walid, Dorresteijn, Kirsten R.I.S., Hensen, Jan-Hein, van Es, Adriaan C.G.M., van der Lugt, Aad, Kerkhoff, Henk, Dippel, Diederik W.J., Goyal, Mayank, Roozenbeek, Bob, Lingsma, Hester F, Vermeij, Frédérique H, Lingsma, Hester F, Rozeman, Anouk D, Vermeij, Frédérique H, Alblas, Kees C L, Mulder, Laus J M M, Wijnhoud, Annemarie D, Maasland, Lisette, van Eijkelenburg, Roeland P J, Biekart, Marileen, Willeboer, M L, Buijck, Bianca, van Doormaal, Pieter Jan, Bakker, Jeannette, Plaisier, Aarnout, Nijeholt, Geert Lycklama à, Hoek, Amber, Rozeman, Anouk D, Bakker, Jeannette, Oskam, Erick, Vermeij, Frédérique H, van der Zon, Mandy M A, Zwets, Egon D, Alblas, Kees C L, Mulder, Laus J M M, Kuiper, Jan Willem, Wijnhoud, Annemarie D, van Moll, Bruno J M, Plaisier, Aarnout, Maasland, Lisette, Woudenberg, Mirjam, van Eijkelenburg, Roeland P J, de Leeuw, Arnoud M, Noordam-Reijm, Anja, Bevelander, Timo, Chalos, Vicky, Wiegers, Eveline J A, Wolff, /Lennard, van Kalkeren, Dennis C, and van den Biggelaar, Jochem
- Published
- 2022
- Full Text
- View/download PDF
31. Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials
- Author
-
Tanaka, Koji, Goyal, Mayank, Menon, Bijoy K., Campbell, Bruce C.V., Mitchell, Peter J., Jovin, Tudor G., Dávalos, Antoni, Jansen, Olav, Muir, Keith W., White, Phil M., Bracard, Serge, Achit, Hamza, Dippel, Diederik W.J., Majoie, Charles B.L.M., Hill, Michael D., Brown, Scott, and Demchuk, Andrew M.
- Published
- 2022
- Full Text
- View/download PDF
32. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
- Author
-
Yang, Pengfei, Song, Lili, Zhang, Yongwei, Zhang, Xiaoxi, Chen, Xiaoying, Li, Yunke, Sun, Lingli, Wan, Yingfeng, Billot, Laurent, Li, Qiang, Ren, Xinwen, Shen, Hongjian, Zhang, Lei, Li, Zifu, Xing, Pengfei, Zhang, Yongxin, Zhang, Ping, Hua, Weilong, Shen, Fang, Zhou, Yihan, Tian, Bing, Chen, Wenhuo, Han, Hongxing, Zhang, Liyong, Xu, Chenghua, Li, Tong, Peng, Ya, Yue, Xincan, Chen, Shengli, Wen, Changming, Wan, Shu, Yin, Congguo, Wei, Ming, Shu, Hansheng, Nan, Guangxian, Liu, Sheng, Liu, Wenhua, Cai, Yiling, Sui, Yi, Chen, Maohua, Zhou, Yu, Zuo, Qiao, Dai, Dongwei, Zhao, Rui, Li, Qiang, Huang, Qinghai, Xu, Yi, Deng, Benqiang, Wu, Tao, Lu, Jianping, Wang, Xia, Parsons, Mark W, Butcher, Ken, Campbell, Bruce, Robinson, Thompson G, Goyal, Mayank, Dippel, Diederik, Roos, Yvo, Majoie, Charles, Wang, Longde, Wang, Yongjun, Liu, Jianmin, and Anderson, Craig S
- Abstract
The optimum systolic blood pressure after endovascular thrombectomy for acute ischaemic stroke is uncertain. We aimed to compare the safety and efficacy of blood pressure lowering treatment according to more intensive versus less intensive treatment targets in patients with elevated blood pressure after reperfusion with endovascular treatment.
- Published
- 2022
- Full Text
- View/download PDF
33. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment
- Author
-
Rinkel, Leon A., Treurniet, Kilian M., Nieboer, Daan, Kappelhof, Manon, LeCouffe, Natalie E., Bruggeman, Agnetha A.E., van Zwam, Wim H., Lycklama à Nijeholt, Geert J., Ghariq, Elyas, Uyttenboogaart, Maarten, Dippel, Diederik W.J., Roos, Yvo B.W.E.M., Coutinho, Jonathan M., Majoie, Charles B.L.M., Emmer, Bart J., Roozenbeek, Bob, van Es, Adriaan, de Ridder, Inger, van der Worp, Bart, Lo, Rob, Keizer, Koos, Gons, Rob, Yo, Lonneke, Boiten, Jelis, van den Wijngaard, Ido, Hofmeijer, Jeanette, Martens, Jasper, Schonewille, Wouter, Albert Vos, Jan, Tuladhar, Anil, Schreuder, Floris, Boogaarts, Jeroen, Jenniskens, Sjoerd, de Laat, Karlijn, van Dijk, Lukas, den Hertog, Heleen, van Hasselt, Boudewijn, Brouwers, Paul, Sturm, Emiel, Bulut, Tomas, Remmers, Michel, van Norden, Anouk, de Jong, Thijs, Rozeman, Anouk, Elgersma, Otto, Bokkers, Reinoud, van Tuijl, Julia, Boukrab, Issam, Kortman, Hans, Costalat, Vincent, Arquizan, Caroline, Lemmens, Robin, Demeestere, Jelle, Desfontaines, Philippe, Brisbois, Denis, Clarençon, Frédéric, Samson, Yves, van Es, Adriaan, Boiten, Jelis, Yo, Lonneke, Keizer, Koos, Brown, Martin, White, Phil, Gregson, John, van Nuland, Rick, van der Lugt, Aad, Jacobi, Linda, van den Berg, René, Beenen, Ludo, van Es, Adriaan, van Doormaal, Pieter-Jan, van den Wijngaard, Ido, Yoo, Albert, Yo, Lonneke, Martens, Jasper, Hammer, Bas, Roosendaal, Stefan, Meijer, Anton, Krietemeijer, Menno, Bokkers, Reinoud, van der Hoorn, Anouk, Gerrits, Dick, van Oostenbrugge, Robert, Jansen, Ben, Manschot, Sanne, Kerkhof, Henk, van den Wijngaard, Ido, Koudstaal, Peter, Keizer, Koos, Lingsma, Hester, Chalos, Vicky, Berkhemer, Olvert, van der Lugt, Aad, Versteeg, Adriaan, Wolff, Lennard, Su, Jiahang, Tolhuisen, Manon, van Voorst, Henk, ten Cate, Hugo, de Maat, Moniek, Donse-Donkel, Samantha, van Beusekom, Heleen, Taha, Aladdin, Chalos, Vicky, van den Berg, Sophie, van de Graaf, Rob, Goldhoorn, Robert-Jan, Taha, Aladdin, Donse-Donkel, Samantha, Hinsenveld, Wouter, Pirson, Anne, Sondag, Lotte, Reinink, Rik, Tolhuisen, Manon, Brouwer, Josje, Wolff, Lennard, Collette, Sabine, van der Steen, Wouter, Sprengers, Rita, Sterrenberg, Martin, El Ghannouti, Naziha, Verheesen, Sabrina, Pellikaan, Wilma, Blauwendraat, Kitty, Drabbe, Yvonne, de Meris, Joke, Simons, Michelle, Bongenaar, Hester, van Loon, Anja, Ponjee, Eva, Eilander, Rieke, Kooij, Suze, de Jong, Marieke, Santegoets, Esther, Roodenburg, Suze, van Ahee, Ayla, Moynier, Marinette, Devroye, Annemie, Marcis, Evelyn, Iezzi, Ingrid, David, Annie, Talbi, Atika, Heiligers, Leontien, and Martens, Yvonne
- Published
- 2022
- Full Text
- View/download PDF
34. Cerebral Collateral Circulation in the Era of Reperfusion Therapies for Acute Ischemic Stroke
- Author
-
Uniken Venema, Simone M., Dankbaar, Jan Willem, van der Lugt, Aad, Dippel, Diederik W.J., and van der Worp, H. Bart
- Abstract
Clinical outcomes of patients with acute ischemic stroke depend in part on the extent of their collateral circulation. A good collateral circulation has also been associated with greater benefit of intravenous thrombolysis and endovascular treatment. Treatment decisions for these reperfusion therapies are increasingly guided by a combination of clinical and imaging parameters, particularly in later time windows. Computed tomography and magnetic resonance imaging enable a rapid assessment of both the collateral extent and cerebral perfusion. Yet, the role of the collateral circulation in clinical decision-making is currently limited and may be underappreciated due to the use of rather coarse and rater-dependent grading methods. In this review, we discuss determinants of the collateral circulation in patients with acute ischemic stroke, report on commonly used and emerging neuroimaging techniques for assessing the collateral circulation, and discuss the therapeutic and prognostic implications of the collateral circulation in relation to reperfusion therapies for acute ischemic stroke.
- Published
- 2022
- Full Text
- View/download PDF
35. Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study
- Author
-
van der Steen, Wouter, van der Ende, Nadinda A.M., van Kranendonk, Katinka R., Chalos, Vicky, van Oostenbrugge, Robert J., van Zwam, Wim H., Roos, Yvo B.W.E.M., van Doormaal, Pieter J., van Es, Adriaan C.G.M., Lingsma, Hester F., Majoie, Charles B.L.M., van der Lugt, Aad, Dippel, Diederik W.J., and Roozenbeek, Bob
- Published
- 2022
- Full Text
- View/download PDF
36. Surveillance of Unruptured Intracranial Aneurysms
- Author
-
Cras, Tim Yannick, Hunink, Myriam M.G., Dammers, Ruben, van Es, Adriaan C.G.M., Volovici, Victor, Burke, James F., Kremers, Femke C.C., Dippel, Diederik W.J., and Roozenbeek, Bob
- Published
- 2022
- Full Text
- View/download PDF
37. Etiology of Large Vessel Occlusion Posterior Circulation Stroke: Results of the MR CLEAN Registry
- Author
-
Pirson, F.A.V. (Anne), Boodt, Nikki, Brouwer, Josje, Bruggeman, Agnetha A.E., Hinsenveld, Wouter H., Staals, Julie, van Zwam, Wim H., van der Leij, Christiaan, Brans, Rutger J.B., Majoie, Charles B.L.M., Dippel, Diederik W.J., van der Lugt, Aad, Schonewille, Wouter J., and van Oostenbrugge, Robert J.
- Published
- 2022
- Full Text
- View/download PDF
38. Functional Outcomes of Patients ≥85 Years With Acute Ischemic Stroke Following EVT: A HERMES Substudy
- Author
-
McDonough, Rosalie V., Ospel, Johanna M., Campbell, Bruce C.V., Hill, Michael D., Saver, Jeffrey L., Dippel, Diederik W.J., Demchuk, Andrew M., Majoie, Charles B.L.M., Brown, Scott B., Mitchell, Peter J., Bracard, Serge, Guillemin, Francis, Jovin, Tudor G., Muir, Keith W., White, Philip, and Goyal, Mayank
- Published
- 2022
- Full Text
- View/download PDF
39. Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry
- Author
-
Compagne, Kars C.J., Kappelhof, Manon, Hinsenveld, Wouter H., Brouwer, Josje, Goldhoorn, Robert-Jan B., Uyttenboogaart, Maarten, Bokkers, Reinoud P.H., Schonewille, Wouter J., Martens, Jasper M., Hofmeijer, Jeannette, van der Worp, H. Bart, Lo, Rob T.H., Keizer, Koos, Yo, Lonneke S.F., Lycklama à Nijeholt, Geert J., den Hertog, Heleen M., Sturm, Emiel J.C., Brouwers, Paul J.A.M., van Walderveen, Marianne A.A., Wermer, Marieke J.H., de Bruijn, Sebastiaan F., van Dijk, Lukas C., Boogaarts, Hieronymus D., van Dijk, Ewout J., van Tuijl, Julia H., Peluso, Jo P.P., de Kort, Paul L.M., van Hasselt, Boudewijn A.A.M., Fransen, Puck S., Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Jenniskens, Sjoerd F.M., Sprengers, Marieke E.S., Ghariq, Elias, van den Wijngaard, Ido R., Roosendaal, Stefan D., Meijer, Anton F.J.A., Beenen, Ludo F.M., Postma, Alida A., van den Berg, René, Yoo, Albert J., van Doormaal, Pieter Jan, van Proosdij, Marc P., Krietemeijer, Menno G.M., Gerrits, Dick G., Hammer, Sebastiaan, Vos, Jan Albert, Boiten, Jelis, Coutinho, Jonathan M., Emmer, Bart J., van Es, Ad C.G.M., Roozenbeek, Bob, Roos, Yvo B.W.E.M., van Zwam, Wim H., van Oostenbrugge, Robert J., Majoie, Charles B.L.M., Dippel, Diederik W.J., and van der Lugt, Aad
- Published
- 2022
- Full Text
- View/download PDF
40. Thrombectomy With and Without Computed Tomography Perfusion Imaging in the Early Time Window: A Pooled Analysis of Patient-Level Data
- Author
-
Jadhav, Ashutosh P., Goyal, Mayank, Ospel, Johanna, Campbell, Bruce C., Majoie, Charles B.L.M., Dippel, Diederik W., White, Phil, Bracard, Serge, Guillemin, Francis, Davalos, Antoni, Hill, Michael D., Demchuk, Andrew M., Brown, Scott, Saver, Jeffrey L., Muir, Keith W., Mitchell, Peter, Desai, Shashvat M., and Jovin, Tudor G.
- Published
- 2022
- Full Text
- View/download PDF
41. Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?
- Author
-
Taha, Aladdin, Bobi, Joaquim, Dammers, Ruben, Dijkhuizen, Rick M., Dreyer, Antje Y., van Es, Adriaan C.G.M., Ferrara, Fabienne, Gounis, Matthew J., Nitzsche, Björn, Platt, Simon, Stoffel, Michael H., Volovici, Victor, del Zoppo, Gregory J., Duncker, Dirk J., Dippel, Diederik W.J., Boltze, Johannes, and van Beusekom, Heleen M.M.
- Abstract
Translation of acute ischemic stroke research to the clinical setting remains limited over the last few decades with only one drug, recombinant tissue-type plasminogen activator, successfully completing the path from experimental study to clinical practice. To improve the selection of experimental treatments before testing in clinical studies, the use of large gyrencephalic animal models of acute ischemic stroke has been recommended. Currently, these models include, among others, dogs, swine, sheep, and nonhuman primates that closely emulate aspects of the human setting of brain ischemia and reperfusion. Species-specific characteristics, such as the cerebrovascular architecture or pathophysiology of thrombotic/ischemic processes, significantly influence the suitability of a model to address specific research questions. In this article, we review key characteristics of the main large animal models used in translational studies of acute ischemic stroke, regarding (1) anatomy and physiology of the cerebral vasculature, including brain morphology, coagulation characteristics, and immune function; (2) ischemic stroke modeling, including vessel occlusion approaches, reproducibility of infarct size, procedural complications, and functional outcome assessment; and (3) implementation aspects, including ethics, logistics, and costs. This review specifically aims to facilitate the selection of the appropriate large animal model for studies on acute ischemic stroke, based on specific research questions and large animal model characteristics.
- Published
- 2022
- Full Text
- View/download PDF
42. Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: the CHIP prediction rule
- Author
-
Smits, Marion, Dippel, Diederik W.J., Steyerberg, Ewout W., de Haan, Gijs G., Dekker, Helena M., Vos, Pieter E., Kool, Digna R., Nederkoorn, Paul J., Hofman, Paul A.M., Twijnstra, Albert, Tanghe, Herve L.J., and Hunink, M.G. Myriam
- Subjects
CT imaging -- Usage ,Head injuries -- Diagnosis ,Health - Abstract
Background: Prediction rules for patients with minor head injury suggest that the use of computed tomography (CT) may be limited to certain patients at risk for intracranial complications. These rules apply only to patients with a history of loss of consciousness, which is frequently absent. Objective: To develop a prediction rule for the use of CT in patients with minor head injury, regardless of the presence or absence of a history of loss of consciousness. Design: Prospective, observational study. Setting: 4 university hospitals in the Netherlands that participated in the CT in Head Injury Patients (CHIP) study. Patients: Consecutive adult patients with minor head injury ([greater than or equal to] 16 years of age) with a Glasgow Coma Scale (GCS) score of 13 to 14 or with a GCS score of 15 and at least 1 risk factor. Measurements: Outcomes were any intracranial traumatic CT finding and neurosurgical intervention. The authors performed logistic regression analysis by using variables from existing prediction rules and guidelines, with internal validation by using bootstrapping. Results: 3181 patients were included (February 2002 to August 2004): 243 (7.6%) had intracranial traumatic CT findings and 17 (0.5%) underwent neurosurgical intervention. A detailed prediction rule was developed from which a simple rule was derived. Sensitivity of both rules was 100% for neurosurgical interventions, with an associated specificity of 23% to 30%. For intracranial traumatic CT findings, sensitivity and specificity were 94% to 96% and 25% to 32%, respectively. Potential CT reduction by implementing the rediction rule was 23% to 30%. Internal validation showed slight opimism for the model's performance. Limitation: External validation of the prediction model will be required. Conclusion: The authors propose the highly sensitive CHIP prediction rule for the selective use of CT in patients with minor head injury with or without loss of consciousness.
- Published
- 2007
43. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial
- Author
-
van der Steen, Wouter, van de Graaf, Rob A, Chalos, Vicky, Lingsma, Hester F, van Doormaal, Pieter Jan, Coutinho, Jonathan M, Emmer, Bart J, de Ridder, Inger, van Zwam, Wim, van der Worp, H Bart, van der Schaaf, Irene, Gons, Rob A R, Yo, Lonneke S F, Boiten, Jelis, van den Wijngaard, Ido, Hofmeijer, Jeannette, Martens, Jasper, Schonewille, Wouter, Vos, Jan Albert, Tuladhar, Anil Man, de Laat, Karlijn F, van Hasselt, Boudewijn, Remmers, Michel, Vos, Douwe, Rozeman, Anouk, Elgersma, Otto, Uyttenboogaart, Maarten, Bokkers, Reinoud P H, van Tuijl, Julia, Boukrab, Issam, van den Berg, René, Beenen, Ludo F M, Roosendaal, Stefan D, Postma, Alida Annechien, Krietemeijer, Menno, Lycklama, Geert, Meijer, Frederick J A, Hammer, Sebastiaan, van der Hoorn, Anouk, Yoo, Albert J, Gerrits, Dick, Truijman, Martine T B, Zinkstok, Sanne, Koudstaal, Peter J, Manschot, Sanne, Kerkhoff, Henk, Nieboer, Daan, Berkhemer, Olvert, Wolff, Lennard, van der Sluijs, P Matthijs, van Voorst, Henk, Tolhuisen, Manon, Roos, Yvo B W E M, Majoie, Charles B L M, Staals, Julie, van Oostenbrugge, Robert J, Jenniskens, Sjoerd F M, van Dijk, Lukas C, den Hertog, Heleen M, van Es, Adriaan C G M, van der Lugt, Aad, Dippel, Diederik W J, and Roozenbeek, Bob
- Abstract
Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess the safety and efficacy of intravenous aspirin, unfractionated heparin, both, or neither started during endovascular treatment in patients with ischaemic stroke.
- Published
- 2022
- Full Text
- View/download PDF
44. Endovascular Treatment for Posterior Circulation Stroke in Routine Clinical Practice: Results of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry
- Author
-
Pirson, F. Anne V., Boodt, Nikki, Brouwer, Josje, Bruggeman, Agnetha A.E., den Hartog, Sanne J., Goldhoorn, Robert-Jan B., Langezaal, Lucianne C.M., Staals, Julie, van Zwam, Wim H., van der Leij, Christiaan, Brans, Rutger J.B., Majoie, Charles B.L.M., Coutinho, Jonathan M., Emmer, Bart J., Dippel, Diederik W.J., van der Lugt, Aad, Vos, Jan-Albert, van Oostenbrugge, Robert J., and Schonewille, Wouter J.
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2022
- Full Text
- View/download PDF
45. Economic Evaluation of Endovascular Treatment for Acute Ischemic Stroke
- Author
-
van den Berg, Lucie A., Berkhemer, Olvert A., Fransen, Puck S.S., Beumer, Debbie, Lingsma, Hester, Majoie, Charles B.M., Dippel, Diederik W.J., van der Lugt, Aad, van Oostenbrugge, Robert J., van Zwam, Wim H., Roos, Yvo B., and Dijkgraaf, Marcel G.W.
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2022
- Full Text
- View/download PDF
46. Outcome Prediction Models for Endovascular Treatment of Ischemic Stroke: Systematic Review and External Validation
- Author
-
Kremers, Femke, Venema, Esmee, Duvekot, Martijne, Yo, Lonneke, Bokkers, Reinoud, Lycklama À. Nijeholt, Geert, van Es, Adriaan, van der Lugt, Aad, Majoie, Charles, Burke, James, Roozenbeek, Bob, Lingsma, Hester, and Dippel, Diederik
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2022
- Full Text
- View/download PDF
47. Prediction of Stroke Infarct Growth Rates by Baseline Perfusion Imaging
- Author
-
Wouters, Anke, Robben, David, Christensen, Soren, Marquering, Henk A., Roos, Yvo B.W.E.M., van Oostenbrugge, Robert J., van Zwam, Wim H., Dippel, Diederik W.J., Majoie, Charles B.L.M., Schonewille, Wouter J., van der Lugt, Aad, Lansberg, Maarten, Albers, Gregory W., Suetens, Paul, and Lemmens, Robin
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2022
- Full Text
- View/download PDF
48. Diagnostic performance of an algorithm for automated large vessel occlusion detection on CT angiography
- Author
-
Luijten, Sven P R, Wolff, Lennard, Duvekot, Martijne H C, van Doormaal, Pieter-Jan, Moudrous, Walid, Kerkhoff, Henk, Lycklama a Nijeholt, Geert J, Bokkers, Reinoud P H, Yo, Lonneke S F, Hofmeijer, Jeannette, van Zwam, Wim H, van Es, Adriaan C G M, Dippel, Diederik W J, Roozenbeek, Bob, and van der Lugt, Aad
- Abstract
BackgroundMachine learning algorithms hold the potential to contribute to fast and accurate detection of large vessel occlusion (LVO) in patients with suspected acute ischemic stroke. We assessed the diagnostic performance of an automated LVO detection algorithm on CT angiography (CTA).MethodsData from the MR CLEAN Registry and PRESTO were used including patients with and without LVO. CTA data were analyzed by the algorithm for detection and localization of LVO (intracranial internal carotid artery (ICA)/ICA terminus (ICA-T), M1, or M2). Assessments done by expert neuroradiologists were used as reference. Diagnostic performance was assessed for detection of LVO and per occlusion location by means of sensitivity, specificity, and area under the curve (AUC).ResultsWe analyzed CTAs of 1110 patients from the MR CLEAN Registry (median age (IQR) 71 years (60–80); 584 men; 1110 with LVO) and of 646 patients from PRESTO (median age (IQR) 73 years (62–82); 358 men; 141 with and 505 without LVO). For detection of LVO, the algorithm yielded a sensitivity of 89% in the MR CLEAN Registry and a sensitivity of 72%, specificity of 78%, and AUC of 0.75 in PRESTO. Sensitivity per occlusion location was 88% for ICA/ICA-T, 94% for M1, and 72% for M2 occlusion in the MR CLEAN Registry, and 80% for ICA/ICA-T, 95% for M1, and 49% for M2 occlusion in PRESTO.ConclusionThe algorithm provided a high detection rate for proximal LVO, but performance varied significantly by occlusion location. Detection of M2 occlusion needs further improvement.
- Published
- 2022
- Full Text
- View/download PDF
49. Predictors of poor outcome despite successful endovascular treatment for ischemic stroke: results from the MR CLEAN Registry
- Author
-
van de Graaf, Rob A, Samuels, Noor, Chalos, Vicky, Lycklama a Nijeholt, Geert J, van Beusekom, Heleen, Yoo, Albert J, van Zwam, Wim H, Majoie, Charles B L M, Roos, Yvo B W E M, van Doormaal, Pieter Jan, Ben Hassen, Wagih, van der Lugt, Aad, Dippel, Diederik W J, Lingsma, Hester F, van Es, Adriaan C G M, and Roozenbeek, Bob
- Abstract
BackgroundApproximately one-third of patients with ischemic stroke treated with endovascular treatment do not recover to functional independence despite rapid and successful recanalization. We aimed to quantify the importance of predictors of poor functional outcome despite successful reperfusion.MethodsWe analyzed patients from the MR CLEAN Registry between March 2014 and November 2017 with successful reperfusion (extended Thrombolysis In Cerebral Infarction ≥2B). First, predictors were selected based on expert opinion and were clustered according to acquisition over time (ie, baseline patient factors, imaging factors, treatment factors, and postprocedural factors). Second, several models were constructed to predict 90-day functional outcome (modified Rankin Scale (mRS)). The relative importance of individual predictors in the most extensive model was expressed by the proportion of unique added χ2to the model of that individual predictor.ResultsOf 3180 patients, 1913 (60%) had successful reperfusion. Of these 1913 patients, 1046 (55%) were functionally dependent at 90 days (mRS >2). The most important predictors for mRS were baseline patient factors (ie, pre-stroke mRS, added χ20.16; National Institutes of Health Stroke Scale score at baseline, added χ20.12; age, added χ20.10), and postprocedural factors (ie, symptomatic intracranial hemorrhage (sICH), added χ20.12; pneumonia, added χ20.09). The probability of functional independence for a typical stroke patient with sICH was 54% (95% CI 36% to 72%) lower compared with no sICH, and 21% (95% CI 4% to 38%) for pneumonia compared with no pneumonia.ConclusionBaseline patient factors and postprocedural adverse events are important predictors of poor functional outcome in successfully reperfused patients with ischemic stroke. This implies that prevention of postprocedural adverse events has the greatest potential to further improve outcomes in these patients.
- Published
- 2022
- Full Text
- View/download PDF
50. Effect of first pass reperfusion on outcome in patients with posterior circulation ischemic stroke
- Author
-
den Hartog, Sanne J, Roozenbeek, Bob, Boodt, Nikki, Bruggeman, Agnetha A E, van Es, Adriaan C G M, Emmer, Bart J, Majoie, Charles B L M, van den Wijngaard, Ido R, van Doormaal, Pieter Jan, van Zwam, Wim H, Lingsma, Hester F, and Dippel, Diederik W J
- Abstract
BackgroundFirst pass reperfusion (FPR), that is, excellent reperfusion (expanded treatment in cerebral ischemia (eTICI) 2C-3) in one pass, after endovascular treatment (EVT) of an occluded artery in the anterior circulation, is associated with favorable clinical outcome, even when compared with multiple pass excellent reperfusion (MPR). In patients with posterior circulation ischemic stroke (PCS), the same association is expected, but currently unknown. We aimed to assess characteristics associated with FPR and the influence of FPR versus MPR on outcomes in patients with PCS.MethodsWe used data from the MR CLEAN Registry, a prospective observational study. The effect of FPR on 24-hour National Institutes of Health Stroke Scale (NIHSS) score, as percentage reduction, and on modified Rankin Scale (mRS) scores at 3 months, was tested with linear and ordinal logistic regression models.ResultsOf 224 patients with PCS, 45 patients had FPR, 47 had MPR, and 90 had no excellent reperfusion (eTICI <2C). We did not find an association between any of the patient, imaging, or treatment characteristics and FPR. FPR was associated with better NIHSS (−45% (95% CI: −65% to −12%)) and better mRS scores (adjusted common odds ratio (acOR): 2.16 (95% CI: 1.23 to 3.79)) compared with no FPR. Outcomes after FPR were also more favorable compared with MPR, but the effect was smaller and not statistically significant (NIHSS: −14% (95% CI: −51% to 49%), mRS acOR: 1.50 (95% CI: 0.75 to 3.00)).ConclusionsFPR in patients with PCS is associated with favorable clinical outcome in comparison with no FPR. In comparison with MPR, the effect of FPR was no longer statistically significant. Nevertheless, our data support the notion that FPR should be the treatment target to pursue in every patient treated with EVT.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.